Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

Cited In for PubMed (Select 9135733)

1.

Gene therapy for the treatment of cystic fibrosis.

Burney TJ, Davies JC.

Appl Clin Genet. 2012 May 29;5:29-36. doi: 10.2147/TACG.S8873. Print 2012.

2.

Adenoviral gene transfer corrects the ion transport defect in the sinus epithelia of a porcine CF model.

Potash AE, Wallen TJ, Karp PH, Ernst S, Moninger TO, Gansemer ND, Stoltz DA, Zabner J, Chang EH.

Mol Ther. 2013 May;21(5):947-53. doi: 10.1038/mt.2013.49. Epub 2013 Mar 19.

3.

Manganese-loaded lipid-micellar theranostics for simultaneous drug and gene delivery to lungs.

Howell M, Mallela J, Wang C, Ravi S, Dixit S, Garapati U, Mohapatra S.

J Control Release. 2013 Apr 28;167(2):210-8. doi: 10.1016/j.jconrel.2013.01.029. Epub 2013 Feb 6.

4.

Advances in cell and gene-based therapies for cystic fibrosis lung disease.

Oakland M, Sinn PL, McCray PB Jr.

Mol Ther. 2012 Jun;20(6):1108-15. doi: 10.1038/mt.2012.32. Epub 2012 Feb 28. Review.

5.

Gene therapy for ALI/ARDS.

Lin X, Dean DA.

Crit Care Clin. 2011 Jul;27(3):705-18. doi: 10.1016/j.ccc.2011.04.002. Review.

6.

Lipidic systems for in vivo siRNA delivery.

Wu SY, McMillan NA.

AAPS J. 2009 Dec;11(4):639-52. doi: 10.1208/s12248-009-9140-1. Epub 2009 Sep 9. Review.

7.

Women and heart disease--physiologic regulation of gene delivery and expression: bioreducible polymers and ischemia-inducible gene therapies for the treatment of ischemic heart disease.

Yockman JW, Kim SW, Bull DA.

Adv Drug Deliv Rev. 2009 Aug 10;61(10):863-70. doi: 10.1016/j.addr.2009.04.013. Epub 2009 May 5. Review.

8.

Novel polymer carriers and gene constructs for treatment of myocardial ischemia and infarction.

Yockman JW, Kastenmeier A, Erickson HM, Brumbach JG, Whitten MG, Albanil A, Li DY, Kim SW, Bull DA.

J Control Release. 2008 Dec 18;132(3):260-6. doi: 10.1016/j.jconrel.2008.06.024. Epub 2008 Jul 6. Review.

9.

Detection of cystic fibrosis transmembrane conductance regulator activity in early-phase clinical trials.

Rowe SM, Accurso F, Clancy JP.

Proc Am Thorac Soc. 2007 Aug 1;4(4):387-98. Review.

10.

Novel molecular approaches to cystic fibrosis gene therapy.

Lee TW, Matthews DA, Blair GE.

Biochem J. 2005 Apr 1;387(Pt 1):1-15. Review.

11.

Current status of gene therapy for inherited lung diseases.

Driskell RA, Engelhardt JF.

Annu Rev Physiol. 2003;65:585-612. Epub 2002 May 1. Review.

12.

Taking stock of gene therapy for cystic fibrosis.

Stern M, Geddes DM, Alton EW.

Respir Res. 2000;1(2):78-81. Epub 2000 Sep 15. Review.

13.

Bad for cats, good for humans? Modified feline immunodeficiency virus for gene therapy.

Crystal RG.

J Clin Invest. 1999 Dec;104(11):1491-3. No abstract available.

14.

Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus.

Harvey BG, Leopold PL, Hackett NR, Grasso TM, Williams PM, Tucker AL, Kaner RJ, Ferris B, Gonda I, Sweeney TD, Ramalingam R, Kovesdi I, Shak S, Crystal RG.

J Clin Invest. 1999 Nov;104(9):1245-55.

15.

Comparison of DNA-lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo.

Zabner J, Cheng SH, Meeker D, Launspach J, Balfour R, Perricone MA, Morris JE, Marshall J, Fasbender A, Smith AE, Welsh MJ.

J Clin Invest. 1997 Sep 15;100(6):1529-37.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk